Hawkins
Hawkins' revenue rose 11.2% to $1.1 billion in fiscal 2026. Its operating margin was 11.2%, down from 12.2% a year earlier. Free cash flow was $86 million, up 23.0%. It paid out $16 million in dividends and buybacks, 18% of free cash flow. The diluted share count fell 0.4%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2017 to 2026, earnings per share grew 15.6% a year and net income 15.3% a year, as buybacks cut the share count by 1%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Hawkins yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Hawkins' 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Hawkins' fiscal 2026 free cash flow of $86M, net cash of −$240M at March 29, 2026 and 21 million diluted shares, from its filings. The scenarios are fitted to Hawkins: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 5.0% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 12%: 11% for a cyclical or higher-risk business (Commodity Chemicals), plus 1 point as a smaller company, worth $2.8B; the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $135.44
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Hawkins' earnings per share of $4.12 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 29×, the middle of Hawkins' own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 13%, 12% and 11%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $135.44
- Value at this multiple, against the last close
- —
- Hawkins' P/E at the last close
- 32.9×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| HawkinsHWKN | $135.44 | $4.12 | 32.9× |
| BalchemBCPC | $170.62 | $5.31 | 32.1× |
| Royal GoldRGLD | $234.11 | $9.04 | 25.9× |
Balance sheet
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | 4 | 8 | 7 | 5 | 4 |
| Debt incl. finance leases | 126 | 112 | 99 | 149 | 244 |
| Net debt (negative means net cash) | 122 | 104 | 92 | 144 | 240 |
| Net debt to EBITDA | 1.3x | 0.9x | 0.7x | 0.9x | 1.4x |
| Debt to equity | 0.4x | 0.3x | 0.2x | 0.3x | 0.5x |
| Interest coverage | 59.5x | 18.5x | 22.4x | 20.6x | 8.9x |
| Current ratio | 2.2x | 2.5x | 2.0x | 2.4x | 2.2x |
| Quick ratio | 1.3x | 1.6x | 1.2x | 1.5x | 1.5x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 4 insiders bought $850,934 of Hawkins shares on the open market, and none sold any.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Jeffrey P. OldenkampExecutive VP and CFO | Bought | 1,290 | $119.00 | $153,510 | Form 4 |
| Aug 25, 2026 | Douglas A. LangeVP - Water Treatment Group | Bought | 910 | $118.75 | $108,062 | Form 4 |
| Feb 5, 2026 | James A FaulconbridgeDirector | Bought | 1,500 | $129.95 | $194,925 | Form 4 |
| Feb 4, 2026 | James A FaulconbridgeDirector | Bought | 1,500 | $129.29 | $193,935 | Form 4 |
| Nov 3, 2025 | Drew M. GrahekVice President of Operations | Bought | 1,587 | $126.34 | $200,502 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Fail |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Pass | Pass | Fail |
| Revenue rose relative to assets | Fail | Fail | Fail |
| F-score | 7 of 9 | 7 of 9 | 4 of 9 |
| Accruals ratio | −13.5% | −3.8% | −7.2% |
Compare
Put Hawkins side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Hawkins | FY26 | 11.2% | 11.2% | 7.9% | 13.1% | 1.4x | 4 | |
| Koppers | FY25 | −10.2% | 8.9% | 3.6% | 8.1% | 3.7x | 8 | Compare |
| Dow | FY25 | −7.0% | — | −3.6% | −4.1% | 12.0x | 3 | Compare |
| Balchem | FY25 | 8.8% | 20.2% | 16.7% | — | — | — | Compare |
| Royal Gold | FY25 | 43.2% | 61.9% | — | 9.7% | 0.8x | 6 | Compare |
10 years of figures
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 484 | 504 | 556 | 540 | 597 | 774 | 935 | 919 | 974 | 1,084 |
| Revenue growth | 16.8% | 4.2% | 10.3% | −2.9% | 10.5% | 29.8% | 20.7% | −1.7% | 6.0% | 11.2% |
| Gross profit | 98 | 87 | 96 | 101 | 124 | 146 | 165 | 194 | 226 | 245 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 39 | −12 | 37 | 42 | 56 | 71 | 88 | 104 | 119 | 121 |
| Net income | 23 | −9 | 24 | 28 | 41 | 52 | 60 | 75 | 84 | 82 |
| Diluted EPS (US$) | 1.06 | −0.43 | 1.14 | 1.33 | 1.93 | 2.44 | 2.86 | 3.59 | 4.03 | 3.91 |
| Diluted shares (millions) | 21 | 21 | 22 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Cash flow | ||||||||||
| Cash from operations | 45 | 27 | 48 | 59 | 44 | 43 | 77 | 160 | 111 | 144 |
| Capital expenditure | 22 | 20 | 13 | 24 | 21 | 28 | 48 | 40 | 41 | 58 |
| Free cash flow | 23 | 8 | 35 | 34 | 23 | 14 | 29 | 119 | 70 | 86 |
| Dividends paid | 9 | 9 | 12 | 10 | 10 | 11 | 12 | 13 | 15 | 16 |
| Share buybacks | 0 | 0 | 4 | 6 | 4 | 8 | 7 | 11 | 21 | 0 |
| Acquisitions | 2 | 0 | 0 | 0 | 51 | 22 | 0 | 84 | 87 | 167 |
| Stock-based compensation | 2 | 1 | 2 | 2 | 3 | 4 | 4 | 5 | 6 | 9 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 7 | 5 | 9 | 4 | 3 | 4 | 8 | 7 | 5 | 4 |
| Debt incl. finance leases | 103 | 101 | 85 | 60 | 99 | 126 | 112 | 99 | 149 | 244 |
| Total assets | 419 | 391 | 386 | 389 | 472 | 567 | 590 | 658 | 770 | 986 |
| Total liabilities | 201 | 189 | 168 | 156 | 207 | 265 | 240 | 252 | 310 | 452 |
| Shareholders' equity | 218 | 202 | 218 | 234 | 265 | 303 | 350 | 406 | 460 | 534 |
| Margins and ratios | ||||||||||
| Gross margin | 20.3% | 17.2% | 17.2% | 18.7% | 20.7% | 18.9% | 17.7% | 21.1% | 23.1% | 22.6% |
| Operating margin | 8.0% | −2.3% | 6.6% | 7.7% | 9.4% | 9.2% | 9.4% | 11.3% | 12.2% | 11.2% |
| Net margin | 4.7% | −1.8% | 4.4% | 5.2% | 6.9% | 6.7% | 6.4% | 8.2% | 8.7% | 7.5% |
| Free cash flow margin | 4.8% | 1.5% | 6.4% | 6.4% | 3.9% | 1.9% | 3.1% | 13.0% | 7.2% | 7.9% |
| Return on capital | 7.8% | −3.0% | 9.1% | 10.4% | 12.6% | 13.3% | 14.6% | 16.3% | 15.9% | 13.1% |
| Return on equity | 10.8% | −4.4% | 11.6% | 12.6% | 16.4% | 18.1% | 18.4% | 19.9% | 19.5% | 16.4% |
| Return on assets | 5.3% | −2.3% | 6.3% | 7.3% | 9.5% | 9.9% | 10.4% | 12.1% | 11.8% | 9.3% |
| Net debt to EBITDA | 1.6x | 9.0x | 1.3x | 0.9x | 1.2x | 1.3x | 0.9x | 0.7x | 0.9x | 1.4x |